logo dark logo light logo
  • THE CAPSULE
  • TRIALS
  • KEY BENEFITS
  • NEWS
  • TEAM
  • CONTACT
logo dark logo light logo
  • THE CAPSULE
  • TRIALS
  • KEY BENEFITS
  • NEWS
  • TEAM
  • CONTACT
mobile-logo
  • THE CAPSULE
  • TRIALS
  • KEY BENEFITS
  • NEWS
  • TEAM
  • CONTACT
Atmo CEO Mal Hebblewhite holding gas-sensing capsule
20 Jul

Atmo Biosciences wins $620K grant to advance commercialization of ingestible gas-sensing capsule to diagnose gut disorders

by atmobio
in News
Comments

Atmo Biosciences has been awarded a $620,000 Australian Government grant through the BioMedTech Horizons (BMTH) program.

Continue reading
Atmo Gas Capsule in palm of hand
02 Jun

Atmo Biosciences raises $2.5m in seed financing

by atmobio
in News
Comments

Atmo Biosciences has raised a further A$2.5 million in an oversubscribed funding round, supplementing an initial seed raise in March 2019.

Continue reading
Atmo Gas Capsule and Daily Synbiotic
22 Nov

Seed Health and Atmo Biosciences announce research partnership to evaluate impact of probiotics on gut microbiome

by atmobio
in News
Comments

Seed Health, a microbial sciences company, is partnering with Atmo Biosciences to use its ingestible gas-sensing capsule to study the impact of probiotics on the gut microbiome.

Continue reading
AusBiotech Logo
04 Nov

Atmo Biosciences wins Early Stage Investment Forum at AusBiotech

by atmobio
in News
Comments

Atmo Biosciences beat 10 other contenders to win the Early Stage Investment Forum (ESIF) at AusBiotech 2019, held at the Melbourne Convention Centre last week.

Continue reading
Dr Chris Roberts
29 Oct

Former Cochlear CEO Dr. Chris Roberts AO joins Atmo Biosciences Board

by atmobio
in News
Comments

Former Cochlear Chief Executive Officer Dr. Chris Roberts AO has been appointed as a Non-Executive Director to the Board of Atmo Biosciences, a digital health business commercializing a world-first ingestible gas-sensing capsule for gut health.

Continue reading
Atmo Biosciences CEO Mal Hebblewhite
23 Sep

Human trials underway for first generation Atmo Gas Capsule

by atmobio
in News
Comments

Two human trials of Atmo Biosciences’ ingestible gas-sensing capsule have begun.

The first trial is being conducted at Monash University and the Alfred Hospital in Melbourne, Australia, in collaboration with the research team led by Professor Peter Gibson and Professor Jane Muir.

Continue reading
23 Sep

Atmo exhibits at Australian Gastroenterology Week

by atmobio
in News
Comments

Atmo Biosciences exhibited at Australian Gastroenterology Week Conference in Adelaide thanks to the generous support of C.R. Kennedy.

Continue reading
01 Oct

Atmo Biosciences signs deal with RMIT University to commercialize ingestible gas-sensing capsule for gut health

by atmobio
in News
Comments

Atmo Biosciences has signed a licensing deal with RMIT University securing the exclusive worldwide rights to commercialize a ground-breaking ingestible gas-sensing capsule.

Continue reading
09 Jan

Swallowable sensors reveal mysteries of human gut health

by atmobio
in News
Comments

Findings from the first human trials of a breakthrough gas-sensing swallowable capsule could revolutionize the way that gut disorders and diseases are prevented and diagnosed.

Continue reading
  • 1
  • 2
email

info@atmobiosciences.com
Australia

Ground Floor, 436 Elgar Road
Box Hill VIC 3128
North America

2724 Loker Ave West
Carlsbad, California 92010

© Atmo Biosciences

Partner

Privacy Policy